IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
27 hedge funds and large institutions have $405K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.7K | |
| 2 | +$14.2K | |
| 3 | +$7.57K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.05K |
| 5 |
NFG
Next Financial Group
Houston,
Texas
|
+$691 |
Top Sellers
| 1 | -$15.3K | |
| 2 | -$12.3K | |
| 3 | -$316 | |
| 4 |
Morgan Stanley
New York
|
-$6 |